Syngene International

Fortrea, headquartered in Durham, North Carolina, is a leading, highly agile, and fiercely independent global contract research organization (CRO) providing highly comprehensive Phase I-IV clinical development and commercialization services to the global life sciences industry. Formed from the strategic spin-off of the clinical development business of Labcorp, Fortrea emerged as a formidable, standalone entity armed with decades of deeply embedded operational experience, vast historical data, and massive global scale.

The organization operates robustly across over 90 countries worldwide, employing tens of thousands of dedicated professionals strictly focused on advancing critical medical research. Fortrea boasts deep, specialized therapeutic expertise in highly complex and demanding fields including oncology, advanced neuroscience, infectious diseases, and rare orphan diseases. They offer a full, comprehensive spectrum of clinical services, including rigorous global clinical trial management, robust biometrics and data management, complex global regulatory affairs consulting, and critical post-approval commercialization support.

Fortrea is highly distinguished in the market by its agile, deeply customer-centric approach, proactively utilizing advanced data analytics and decentralized clinical trial (DCT) methodologies to significantly accelerate patient recruitment and fiercely enhance data quality.

By perfectly combining the vast historical data and robust infrastructure legacy of Labcorp with the highly focused agility of a pure-play CRO, Fortrea deeply partners with innovators globally to bring critical medical treatments to market.